Companion Diagnostics Devices Market - Type: Instruments, Consumables, Software & Services; By Technology: Immunohistochemistry, Molecular Diagnostics, In Situ Hybridization, Others; By Indication: Oncology, Infectious Diseases, Cardiovascular Diseases, Others; By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Others; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9.6 Global Companion Diagnostics Devices Market - Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Region, 2024 - 2031
10. North America Global Companion Diagnostics Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.1.1 Instruments
10.1.2 Consumables
10.1.3 Software & Services
10.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.2.1 Immunohistochemistry
10.2.2 Molecular Diagnostics
10.2.3 In Situ Hybridization
10.2.4 Others
10.3 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.3.1 Oncology
10.3.2 Infectious Diseases
10.3.3 Cardiovascular Diseases
10.3.4 Others
10.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.4.1 Hospitals
10.4.2 Diagnostic Laboratories
10.4.3 Research Institutes
10.4.4 Others
10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.5.1 United States
10.5.2 Canada
10.6 North America
Global Companion Diagnostics Devices Market – Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Country, 2024 - 2031
10.7 Regional Trends Analysis
10.8 North America Global Companion Diagnostics Devices Market Research Report - Company Profiles
10.8.1 Company 1 (United States)
10.8.2 Company 2 (Canada)
10.8.3 Company 3 (Canada)
11. Europe Global Companion Diagnostics Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.1.1 Instruments
11.1.2 Consumables
11.1.3 Software & Services
11.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.2.1 Immunohistochemistry
11.2.2 Molecular Diagnostics
11.2.3 In Situ Hybridization
11.2.4 Others
11.3 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.3.1 Oncology
11.3.2 Infectious Diseases
11.3.3 Cardiovascular Diseases
11.3.4 Others
11.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.4.1 Hospitals
11.4.2 Diagnostic Laboratories
11.4.3 Research Institutes
11.4.4 Others
11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.5.1 Germany
11.5.2 United Kingdom
11.5.3 France
11.5.4 Spain
11.5.5 Italy
11.5.6 Russia
11.5.7 Netherlands
11.5.8 Poland
11.5.9 Rest of Europe
11.6 Europe
Global Companion Diagnostics Devices Market – Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Country, 2024 - 2031
11.7 Regional Trends Analysis
11.8 Europe Global Companion Diagnostics Devices Market Research Report - Company Profiles
11.8.1 Company 1 (Germany)
11.8.2 Company 2 (United Kingdom)
11.8.3 Company 3 (United Kingdom)
12. Asia-Pacific Global Companion Diagnostics Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.1.1 Instruments
12.1.2 Consumables
12.1.3 Software & Services
12.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.2.1 Immunohistochemistry
12.2.2 Molecular Diagnostics
12.2.3 In Situ Hybridization
12.2.4 Others
12.3 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.3.1 Oncology
12.3.2 Infectious Diseases
12.3.3 Cardiovascular Diseases
12.3.4 Others
12.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.4.1 Hospitals
12.4.2 Diagnostic Laboratories
12.4.3 Research Institutes
12.4.4 Others
12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4 South Korea
12.5.5 Australia & NZ
12.5.6 ASEAN
12.5.7 Rest of Asia-Pacific
12.6 Asia-Pacific
Global Companion Diagnostics Devices Market – Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Country, 2024 - 2031
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Companion Diagnostics Devices Market Research Report - Company Profiles
12.8.1 Company 1 (China)
12.8.2 Company 2 (Japan)
12.8.3 Company 3 (Japan)
13. Latin America Global Companion Diagnostics Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.1.1 Instruments
13.1.2 Consumables
13.1.3 Software & Services
13.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.2.1 Immunohistochemistry
13.2.2 Molecular Diagnostics
13.2.3 In Situ Hybridization
13.2.4 Others
13.3 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.3.1 Oncology
13.3.2 Infectious Diseases
13.3.3 Cardiovascular Diseases
13.3.4 Others
13.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.4.1 Hospitals
13.4.2 Diagnostic Laboratories
13.4.3 Research Institutes
13.4.4 Others
13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.5.1 Brazil
13.5.2 Mexico
13.5.3 Argentina
13.5.4 Peru
13.5.5 Colombia
13.5.6 Rest of Latin America
13.6 Latin America
Global Companion Diagnostics Devices Market – Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Country, 2024 - 2031
13.7 Regional Trends Analysis
13.8 Latin America Global Companion Diagnostics Devices Market Research Report - Company Profiles
13.8.1 Company 1 (Brazil)
13.8.2 Company 2 (Mexico)
13.8.3 Company 3 (Mexico)
14. Middle East & Africa Global Companion Diagnostics Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.1.1 Instruments
14.1.2 Consumables
14.1.3 Software & Services
14.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.2.1 Immunohistochemistry
14.2.2 Molecular Diagnostics
14.2.3 In Situ Hybridization
14.2.4 Others
14.3 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.3.1 Oncology
14.3.2 Infectious Diseases
14.3.3 Cardiovascular Diseases
14.3.4 Others
14.4 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.4.1 Hospitals
14.4.2 Diagnostic Laboratories
14.4.3 Research Institutes
14.4.4 Others
14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.5.1 Saudi Arabia
14.5.2 UAE
14.5.3 South Africa
14.5.4 Egypt
14.5.5 Israel
14.5.6 Rest of Middle East and Africa
14.6 Middle East & Africa
Global Companion Diagnostics Devices Market – Opportunity Analysis Index,
By Type,
By Technology,
By Indication,
By End User,
and Country, 2024 - 2031
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Companion Diagnostics Devices Market Research Report - Company Profiles
14.8.1 Company 1 (Saudi Arabia)
14.8.2 Company 2 (UAE)
14.8.3 Company 3 (UAE)
15. Competition Landscape
15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
15.2.1 Roche Diagnostics
15.2.2 Abbott Laboratories
15.2.3 Thermo Fisher Scientific Inc.
15.2.4 Agilent Technologies Inc.
15.2.5 Qiagen N.V.
15.2.6 Illumina Inc.
15.2.7 Siemens Healthineers AG
15.2.8 Danaher Corporation
15.2.9 Myriad Genetics Inc.
15.2.10 Almac Group
16. Data Collection Method and Research Approach 17. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.